Mechanisms of Actions of Coenzymes
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A New Mode of B Binding and the Direct Participation of A
Research Article 997 A new mode of B12 binding and the direct participation of a potassium ion in enzyme catalysis: X-ray structure of diol dehydratase Naoki Shibata1, Jun Masuda1, Takamasa Tobimatsu2, Tetsuo Toraya2*, Kyoko Suto1, Yukio Morimoto1 and Noritake Yasuoka1* Background: Diol dehydratase is an enzyme that catalyzes the adenosylcobalamin Addresses: 1Department of Life Science, Himeji (coenzyme B ) dependent conversion of 1,2-diols to the corresponding Institute of Technology, 1475-2 Kanaji, Kamigori, 12 Ako-gun, Hyogo 678-1297, Japan and 2Department aldehydes. The reaction initiated by homolytic cleavage of the cobalt–carbon bond of Bioscience and Biotechnology, Faculty of α β γ of the coenzyme proceeds by a radical mechanism. The enzyme is an 2 2 2 Engineering, Okayama University, Tsushima-Naka, heterooligomer and has an absolute requirement for a potassium ion for catalytic Okayama 700-8530, Japan. activity. The crystal structure analysis of a diol dehydratase–cyanocobalamin *Corresponding authors. complex was carried out in order to help understand the mechanism of action of E-mail: [email protected] this enzyme. [email protected] Results: The three-dimensional structure of diol dehydratase in complex with Key words: B12 enzyme, diol dehydratase, radicals, cyanocobalamin was determined at 2.2 Å resolution. The enzyme exists as a reaction mechanism, TIM barrel αβγ dimer of heterotrimers ( )2. The cobalamin molecule is bound between the Received: 16 March 1999 α and β subunits in the ‘base-on’ mode, that is, 5,6-dimethylbenzimidazole of Revisions requested: 7 April 1999 the nucleotide moiety coordinates to the cobalt atom in the lower axial position. -
Protective Effects of Alpha-Lipoic Acid and Coenzyme Q10 on Lipopolysaccharide-Induced Liver Injury in Rats
Available online a t www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2016, 8 (19):176-182 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4 Protective effects of alpha-lipoic acid and coenzyme Q10 on lipopolysaccharide-induced liver injury in rats Amr M. Emam 1, Gehan S. Georgy 2, Olfat G. Shaker 3, Hala M. Fawzy 2 and Hala F. Zaki 4 1Department of Pharmacology and Toxicology, Faculty of Pharmacy, Misr University for Science and Technology, 6th of October, El motamaiz, Cairo, Egypt 2Department of Pharmacology, National Organization for Drug Control and Research (NODCAR), Giza, Egypt 3Department of Biochemistry, Faculty of Medicine, Cairo University, Kasr El-Aini Street, Cairo, Egypt 4Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo, Egypt _____________________________________________________________________________________________ ABSTRACT Lipopolysaccharide (LPS) is a major cell wall component of gram-negative bacteria known to stimulate the synthesis and secretion of several toxic metabolites, such as reactive oxygen species and cytokines. In this study, the protective effect of alpha-lipoic acid (ALA) and coenzyme Q10 (CoQ10) were evaluated in LPS-induced hepatic injury in rats. To this end, male adult Sprague Dawley rats were divided into five groups; normal control, LPS control where rats were injected with an initial dose of LPS (4 mg/kg; i.p.) on the 1 st day of the experiment followed by a challenging dose (2 mg/kg; i.p.) on the 8 th day, ALA (50 mg/kg), CoQ10 (10 mg/kg) and ALA plus CoQ10. Treatments continued for 15 days and the last three groups also received LPS. -
Pyridoxal Phosphate Is Better Than Pyridoxine for Controlling Idiopathic Intractable Epilepsy
512 ORIGINAL ARTICLE Arch Dis Child: first published as 10.1136/adc.2003.045963 on 25 April 2005. Downloaded from Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy H-S Wang, M-F Kuo, M-L Chou, P-C Hung, K-L Lin, M-Y Hsieh, M-Y Chang ............................................................................................................................... Arch Dis Child 2005;90:512–515. doi: 10.1136/adc.2003.045963 Aim: To study the difference between pyridoxine (PN) and its active form, pyridoxal phosphate, (PLP) in control of idiopathic intractable epilepsy in children. Methods: Among 574 children with active epilepsy, 94 (aged 8 months to 15 years) were diagnosed with idiopathic intractable epilepsy for more than six months. All received intravenous PLP 10 mg/kg, then 10 mg/kg/day in four divided doses. If seizures recurred within 24 hours, another dose of 40 mg/kg was See end of article for given, followed by 50 mg/kg/day in four divided doses. For those patients whose seizures were totally authors’ affiliations controlled, PLP was replaced by the same dose of oral PN. If the seizure recurred, intravenous PLP was ....................... infused followed by oral PLP 50 mg/kg/day. Correspondence to: Results: Fifty seven patients had generalised seizures (of whom 13 had infantile spasms) and 37 had focal Dr M-F Kuo, Division of seizure. Eleven had dramatic and sustained responses to PLP; of these, five also responded to PN. Within (Pediatric) Neurosurgery, six months of treatment with PLP or PN, five of the 11 patients were seizure free and had their previous Department of Surgery, National Taiwan University antiepileptic medicine tapered off gradually. -
Energy + Coq10, NADH & B12
Energy + CoQ10, NADH & B12 it is mainly biosynthesized and concentrated in tissues with high energy turnover. Loss of function in mitochondria, the key organelle responsible for cellular energy production, can result in excess fatigue and other symptoms that are common complaints in almost every chronic disease. At the molecular level, a reduction in mitochondrial function occurs because of the following changes: (1) a loss of maintenance of the electrical and chemical transmembrane potential of the inner mitochondrial membrane, (2) alterations in the function of the electron transport chain, or (3) a reduction in the transport of critical metabolites into mitochondria. In turn, these changes result in reduced efficiency of oxidative phosphorylation and a reduction in adenosine-5’-triphosphate (ATP) production. Several components of this system require routine replacement, which can be facilitated with natural supplements. Clinical trials have shown the utility of using oral replacement supplements, such as coenzyme Q10 (CoQ10 [ubiquinone]), reduced nicotinamide adenine dinucleotide (NADH) and other supplements. Combinations of these supplements can significantly reduce fatigue and other symptoms associated with chronic disease and can naturally restore mitochondrial function, even in long-term patients with intractable fatigue.1 NADH is vital for many human body processes including muscle energy production. Skeletal muscle enables posture, breathing, and locomotion. Skeletal muscle also impacts systemic processes such as metabolism, thermoregulation, and immunity. Skeletal muscle is energetically expensive and is a major consumer of glucose and fatty acids. Metabolism INGREDIENTS of fatty acids and glucose requires NADH, which functions as a hydrogen/ Coenzyme Q10 (CoQ10) electron transfer molecule. Therefore, NADH plays a vital role in energy Coenzyme Q10 is a vitamin-like nutrient central to energy production at production. -
Risk Assessment for Coenzyme Q10 (Ubiquinone) ଝ
Regulatory Toxicology and Pharmacology 45 (2006) 282–288 www.elsevier.com/locate/yrtph Risk assessment for coenzyme Q10 (Ubiquinone) ଝ John N. Hathcock ¤, Andrew Shao Council for Responsible Nutrition, 1828 L Street, NW, Suite 900, Washington, DC 20036-5114, USA Received 24 March 2006 Abstract Coenzyme Q10 (CoQ10) widely occurs in organisms and tissues, and is produced and used as both a drug and dietary supplement. Increasing evidence of health beneWts of orally administered CoQ10 are leading to daily consumption in larger amounts, and this increase justiWes research and risk assessment to evaluate the safety. A large number of clinical trials have been conducted using a range of CoQ10 doses. Reports of nausea and other adverse gastrointestinal eVects of CoQ10 cannot be causally related to the active ingredient because there is no dose–response relationship: the adverse eVects are no more common at daily intakes of 1200 mg than at a 60 mg. Systematic evaluation of the research designs and data do not provide a basis for risk assessment and the usual safe upper level of intake (UL) derived from it unless the newer methods described as the observed safe level (OSL) or highest observed intake (HOI) are utilized. The OSL risk assessment method indicates that the evidence of safety is strong at intakes up to 1200 mg/day, and this level is identiWed as the OSL. Much higher levels have been tested without adverse eVects and may be safe, but the data for intakes above 1200 mg/day are not suYcient for a conWdent conclusion of safety. © 2006 Elsevier Inc. -
Composition: Each
______________________________________________________________________________________________________________ Composition: Each Tablet Contains L-Methylfolate 1mg Mecobalamin 1500 mcg Pyridoxal 5’-phosphate 0.5mg Pharmacokinetic properties: L-methylfolate is a water soluble molecule which is primarily excreted via the kidneys. In a study of subjects with coronary artery disease (n=21), peak plasma levels were reached in 1-3 hours following ORAL/PARENTERAL administration. Peak concentrations of L-methylfolate were found to be more than seven times higher than folic acid (129 ng ml-1 vs. 14.1 ng ml-1) following ORAL/PARENTERAL administration. The mean elimination half-life is approximately 3 hours after 5mg of oral L- methylfolate, administered daily for 7 days. The mean values for Cmax, Tmax, and AUC0-12 were 129 ng ml-1, 1.3 hr., and 383 respectively. Red blood cells (RBCs) appear to be the storage depot for folate, as RBC levels remain elevated for periods in excess of 40 days following discontinuation of supplementation. Plasma protein binding studies showed that L-methylfolate is 56% bound to plasma proteins. Mecobalamin substances bind to intrinsic factor; a glycoprotein secreted by the gastric mucosa, and are then actively absorbed from the gastrointestinal tract. Absorption is impaired in patients with an absence of intrinsic factor, with a malabsorption syndrome or with disease or abnormality of the gut, or after gastrectomy. Absorption from the gastrointestinal tract can also occur by passive diffusion; little of the vitamin present in food is absorbed in this manner although the process becomes increasingly important with larger amounts such as those used therapeutically. After intranasal dosage, peak plasma concentrations of cyanocobalamin have been reached in 1 to 2 hours. -
Annotation Guidelines for Experimental Procedures
Annotation Guidelines for Experimental Procedures Developed By Mohammed Alliheedi Robert Mercer Version 1 April 14th, 2018 1- Introduction and background information What is rhetorical move? A rhetorical move can be defined as a text fragment that conveys a distinct communicative goal, in other words, a sentence that implies an author’s specific purpose to readers. What are the types of rhetorical moves? There are several types of rhetorical moves. However, we are interested in 4 rhetorical moves that are common in the method section of a scientific article that follows the Introduction Methods Results and Discussion (IMRaD) structure. 1- Description of a method: It is concerned with a sentence(s) that describes experimental events (e.g., “Beads with bound proteins were washed six times (for 10 min under rotation at 4°C) with pulldown buffer and proteins harvested in SDS-sample buffer, separated by SDS-PAGE, and analyzed by autoradiography.” (Ester & Uetz, 2008)). 2- Appeal to authority: It is concerned with a sentence(s) that discusses the use of standard methods, protocols, and procedures. There are two types of this move: - A reference to a well-established “standard” method (e.g., the use of a method like “PCR” or “electrophoresis”). - A reference to a method that was previously described in the literature (e.g., “Protein was determined using fluorescamine assay [41].” (Larsen, Frandesn and Treiman, 2001)). 3- Source of materials: It is concerned with a sentence(s) that lists the source of biological materials that are used in the experiment (e.g., “All microalgal strains used in this study are available at the Elizabeth Aidar Microalgae Culture Collection, Department of Marine Biology, Federal Fluminense University, Brazil.” (Larsen, Frandesn and Treiman, 2001)). -
Nicotinamide Adenine Dinucleotide Is Transported Into Mammalian
RESEARCH ARTICLE Nicotinamide adenine dinucleotide is transported into mammalian mitochondria Antonio Davila1,2†, Ling Liu3†, Karthikeyani Chellappa1, Philip Redpath4, Eiko Nakamaru-Ogiso5, Lauren M Paolella1, Zhigang Zhang6, Marie E Migaud4,7, Joshua D Rabinowitz3, Joseph A Baur1* 1Department of Physiology, Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States; 2PARC, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States; 3Lewis-Sigler Institute for Integrative Genomics, Department of Chemistry, Princeton University, Princeton, United States; 4School of Pharmacy, Queen’s University Belfast, Belfast, United Kingdom; 5Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States; 6College of Veterinary Medicine, Northeast Agricultural University, Harbin, China; 7Mitchell Cancer Institute, University of South Alabama, Mobile, United States Abstract Mitochondrial NAD levels influence fuel selection, circadian rhythms, and cell survival under stress. It has alternately been argued that NAD in mammalian mitochondria arises from import of cytosolic nicotinamide (NAM), nicotinamide mononucleotide (NMN), or NAD itself. We provide evidence that murine and human mitochondria take up intact NAD. Isolated mitochondria preparations cannot make NAD from NAM, and while NAD is synthesized from NMN, it does not localize to the mitochondrial matrix or effectively support oxidative phosphorylation. Treating cells *For correspondence: with nicotinamide riboside that is isotopically labeled on the nicotinamide and ribose moieties [email protected] results in the appearance of doubly labeled NAD within mitochondria. Analogous experiments with †These authors contributed doubly labeled nicotinic acid riboside (labeling cytosolic NAD without labeling NMN) demonstrate equally to this work that NAD(H) is the imported species. -
The Influence of Vitamin B12on the Content, Distribution and in Vivo
The Influence of Vitamin B12on the Content, Distribution and in Vivo Synthesis of Thiamine Pyrophosphate, Flavin Adenine Dinucleotide and Pyridine Nucleotides in Rat Liver1 URMILA MARFATIA, D. V. REGE, H. P. TIPNIS ANDA. SREENIVASAN Department of Chemical Technology, University of Bombay, Matunga, Bombay Apart from the well-known interrelation (FAD) and pyridine nucleotides (PN), and ships among the B vitamins, there is rea to their in vivo synthesis from the corre son to believe that folie acid and vitamin sponding administered vitamins, in the rat Downloaded from Bu may influence the functioning of other liver. Data on the distribution of these vitamins as cofactors. Thus, dietary folie cofactors in liver cells of the normal rat acid has been known to determine rat are available in the works of Goethart ('52) liver stores of coenzyme A (CoA) and and Dianzani and Dianzani Mor ('57) on adenotriphosphate (ATP) (Popp and Tot TPP, of Carruthers and Suntzeff ('54) and ter, '52; Totter, '53); a decrease in liver Dianzani ('55) on pyridine nucleotides DPN is also caused by aminopterin2 (PN) and of Schneider and Hogeboom jn.nutrition.org (Strength et al., '54). The in vivo incor (Schneider, '56) on FAD. poration of nitcotinamide into pyridino- nucleotides in rat liver is affected in a EXPERIMENTAL deficiency of vitamin B«(Nadkarni et al., Young, male Wistar rats weighing ap '57). Low blood level of citrovorum factor proximately 100 gm each were used. The by guest on April 19, 2011 in the hyperthyroid, vitamin Bi2-deficient animals, housed individually in raised rat is corrected by administration of vita mesh-bottom cages, were initially depleted min B«(Pfander et al., '52). -
Chemistry and Functions of Proteins
TVER STATE MEDICAL UNIVERSITY BIOCHEMISTRY DEPARTMENT CHEMISTRY AND FUNCTIONS OF PROTEINS ILLUSTRATED BIOCHEMISTRY Schemes, formulas, terms and algorithm of preparation The manual for making notes of lectures and preparation for classes Tver, 2018 AMINO ACIDS -amino acids -These are organic acids with at least a minimum of one of its hydrogen atoms in the carbon chains substituted by an amino group.( Show the radical, amino and carboxyl groups) NH2 R | C – H | COOH Proteinogenous and Nonproteinogenous Amino acids - Major proteinogenous (standard) amino acids. (Give the names of each amino acid) R R 1 H – 2 CH3 – 12 HO – CH2 – (CH3)2 CH – 3 CH3 – CH – (CH3)2 CH – CH2 – 4 13 | CH3 – CH2 – CH – OH 5 | CH 3 6 14 HS – CH2 – HOOC – CH2 – 15 CH3 – S – CH2 – CH2 – 7 HOOC – CH2 – CH2 – NH2 | – C – H - | COOH 8 16 NH2 – CO – CH2 – 9 NH2 – CO – CH2 – CH2 – 17 10 NH2 – (CH2)3 – CH2 – 18 NH2 – C – NH – (CH2)3 – CH2 – 11 || NH 19 20 СООН NH -Glycine -Arginine Alanine -Serine -Valine -Threonine Leucine -Cysteine Isoleucine -Methionine Aspartic acid -Phenylalanine Glutamic acid -Tyrosine Asparagine -Tryptophan Glutamine -Histidine Lysine -Proline •Rare proteinogenous (standard) amino acids. ( Derivatives of lysine, proline and tyrosine) NH2 | H2N – CH2 – CH – (CH2)2 – CH | | OH COOH •Nonproteinogenous amino acids. (Name and show them) NH2 NH2 | | H2N – (CH2)3 – CH HS – (CH2)2 – CH | | COOH COOH NH2 | NH2 – C – HN – (CH2)3 – CH || | O COOH Ornithine Homocysteine Citrulline 2 CLASSIFICATION OF PROTEINOGENOUS (STANDARD) AMINO ACIDS Amino acids are classified by: *The structure of the radical (show); - aliphatic amino acids -monoaminodicarboxylic amino acids -amides of amino acids -diaminomonocarboxylic amino acids -hydroxy amino acids -sulfur-containing amino acids -cyclic (aromatic and heterolytic) amino acids *the polarity of the radical (show); -Non-polar (hydrophobic –Ala, Val, Leu, Ile, Trp, Pro.) -Polar (hydrophilic). -
Chapter 7. "Coenzymes and Vitamins" Reading Assignment
Chapter 7. "Coenzymes and Vitamins" Reading Assignment: pp. 192-202, 207-208, 212-214 Problem Assignment: 3, 4, & 7 I. Introduction Many complex metabolic reactions cannot be carried out using only the chemical mechanisms available to the side-chains of the 20 standard amino acids. To perform these reactions, enzymes must rely on other chemical species known broadly as cofactors that bind to the active site and assist in the reaction mechanism. An enzyme lacking its cofactor is referred to as an apoenzyme whereas the enzyme with its cofactor is referred to as a holoenzyme. Cofactors are subdivided into essential ions and organic molecules known as coenzymes (Fig. 7.1). Essential ions, commonly metal ions, may participate in substrate binding or directly in the catalytic mechanism. Coenzymes typically act as group transfer agents, carrying electrons and chemical groups such as acyl groups, methyl groups, etc., depending on the coenzyme. Many of the coenzymes are derived from vitamins which are essential for metabolism, growth, and development. We will use this chapter to introduce all of the vitamins and coenzymes. In a few cases--NAD+, FAD, coenzyme A--the mechanisms of action will be covered. For the remainder of the water-soluble vitamins, discussion of function will be delayed until we encounter them in metabolism. We also will discuss the biochemistry of the fat-soluble vitamins here. II. Inorganic cation cofactors Many enzymes require metal cations for activity. Metal-activated enzymes require or are stimulated by cations such as K+, Ca2+, or Mg2+. Often the metal ion is not tightly bound and may even be carried into the active site attached to a substrate, as occurs in the case of kinases whose actual substrate is a magnesium-ATP complex. -
Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses
life Review Tricarboxylic Acid (TCA) Cycle Intermediates: Regulators of Immune Responses Inseok Choi , Hyewon Son and Jea-Hyun Baek * School of Life Science, Handong Global University, Pohang, Gyeongbuk 37554, Korea; [email protected] (I.C.); [email protected] (H.S.) * Correspondence: [email protected]; Tel.: +82-54-260-1347 Abstract: The tricarboxylic acid cycle (TCA) is a series of chemical reactions used in aerobic organisms to generate energy via the oxidation of acetylcoenzyme A (CoA) derived from carbohydrates, fatty acids and proteins. In the eukaryotic system, the TCA cycle occurs completely in mitochondria, while the intermediates of the TCA cycle are retained inside mitochondria due to their polarity and hydrophilicity. Under cell stress conditions, mitochondria can become disrupted and release their contents, which act as danger signals in the cytosol. Of note, the TCA cycle intermediates may also leak from dysfunctioning mitochondria and regulate cellular processes. Increasing evidence shows that the metabolites of the TCA cycle are substantially involved in the regulation of immune responses. In this review, we aimed to provide a comprehensive systematic overview of the molecular mechanisms of each TCA cycle intermediate that may play key roles in regulating cellular immunity in cell stress and discuss its implication for immune activation and suppression. Keywords: Krebs cycle; tricarboxylic acid cycle; cellular immunity; immunometabolism 1. Introduction The tricarboxylic acid cycle (TCA, also known as the Krebs cycle or the citric acid Citation: Choi, I.; Son, H.; Baek, J.-H. Tricarboxylic Acid (TCA) Cycle cycle) is a series of chemical reactions used in aerobic organisms (pro- and eukaryotes) to Intermediates: Regulators of Immune generate energy via the oxidation of acetyl-coenzyme A (CoA) derived from carbohydrates, Responses.